The survey effects of botulinum toxin A on quality of life in women with overactive bladder and urge urinary incontinence in patient in Imam Reza Hospital in Kermanshah in 2017

Phase 2

• Conditions: Overactive bladder syndrome.; other specified disorders of bladder

• Registration Number: IRCT20100301003461N10
• Lead Sponsor: Kermanshah University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 11 September 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 20

Inclusion Criteria

Aged over 50 years and Menopause
Married
Having overactive bladder symptoms
Those who have not responded to anticholinergicmedications
Have side effects
Have a BMI of between 20-30
Anticholinergic drugs should not be used for 7 days prior of examination and during treatment
Patients should have a residual urine of 100 cc or Less
Mentally and physically capable of intermittent catheterization
urge urinary incontinence

Exclusion Criteria

Diabetes history
Hypertension history
Neurological Diseases such as multiple sclerosis, Myasthenia Gravis and Stroke, Alzheimer's disease, Psychiatric Disorders,
Major Uterine Masses
History of Chronic Urinary Tract Infections

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of life in women with overactive bladder and urge urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: I-QOL Questionnaire to Measure The Effects of Urge Urinary Incontinence on Quality of Life.;Urinary incontinence. Timepoint: Before Treatment, One Months After treatment,Six Months After Treatment. Method of measurement: Ask the patient.

Secondary Outcome Measures

Name	Time	Method
rinary Tract Infection. Timepoint: Before treatment, one months after treatment,six months after treatment. Method of measurement: Experiment results.;Hematuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Observation and experiment results.;Dysuria. Timepoint: Before treatment, one month after treatment, six months after treatment. Method of measurement: Ask the Patient.